Unlocking the Potential of EF-Hand Calcium Binding Domain 14 as a Drug Target or Biomarker

Target Name: EFCAB14

NCBI ID: G9813

EFCAB14

Other Name(s): EF-hand calcium binding domain 14 | RP11-8J9.3 | KIAA0494 | EFC14_HUMAN | EF-hand calcium-binding domain-containing protein 14

Unlocking the Potential of EF-Hand Calcium Binding Domain 14 as a Drug Target or Biomarker

The protein EF-hand calcium binding domain 14 (EF-CBD14) is a key protein found in various organisms, including bacteria, archaea, and eukaryotes. It is a member of the EF-hand family, which is known for its unique calcium-binding properties. This protein has been identified as a potential drug target or biomarker, due to its unique structure and its involvement in various cellular processes.

Drug Target Potential

The EF-CBD14 protein is of interest as a drug target, due to its ability to interact with calcium ions. This interaction is crucial for the regulation of various cellular processes, including muscle contractions, cell signaling, and intracellular signaling pathways. By targeting the EF-CBD14 protein, researchers may be able to disrupt these processes and prevent the development of certain diseases.

For example, the EF-CBD14 protein has been shown to play a role in the regulation of muscle contractions. In humans, the EF-CBD14 protein is expressed in the muscle and is involved in the regulation of muscle contractions, which is essential for movement and maintaining posture. Researchers have found that mice that lack the EF-CBD14 protein have muscle weakness and are less able to move, suggesting that this protein plays a critical role in the regulation of muscle contractions.

Similarly, the EF-CBD14 protein has also been shown to be involved in intracellular signaling pathways. In various organisms, the EF-CBD14 protein is involved in the regulation of cellular signaling pathways, including cell division, apoptosis (programmed cell death), and inflammation. By targeting this protein, researchers may be able to prevent the development of certain diseases, such as cancer.

Biomarker Potential

The EF-CBD14 protein is also of interest as a potential biomarker, due to its unique structure and its involvement in various cellular processes. This protein has been shown to play a role in the regulation of cellular signaling pathways, including cell division, apoptosis (programmed cell death), and inflammation. By targeting this protein, researchers may be able to monitor the development of certain diseases, such as cancer.

For example, the EF-CBD14 protein has been shown to be involved in the regulation of cell division. In various organisms, the EF-CBD14 protein is involved in the regulation of cell division, including the G1 phase and the S phase. Researchers have found that the EF-CBD14 protein plays a critical role in regulating cell division and that changes in its expression levels can affect the development of certain diseases, such as cancer.

Conclusion

In conclusion, the EF-CBD14 protein is a unique protein that has been identified as a potential drug target or biomarker. Its unique structure and involvement in various cellular processes make it an attractive target for research into the regulation of cellular processes and the development of certain diseases. Further research is needed to fully understand the role of the EF-CBD14 protein in these processes and to develop effective treatments.

Protein Name: EF-hand Calcium Binding Domain 14

The "EFCAB14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EFCAB14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets